Embla Medical hf.
OSSFF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $68 | $59 | $43 | $64 |
| Dep. & Amort. | $56 | $50 | $49 | $52 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$9 | -$13 | -$22 | -$21 |
| Other Non-Cash | $1 | -$1 | -$9 | $6 |
| Operating Cash Flow | $116 | $95 | $61 | $101 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$39 | -$43 | -$26 | -$27 |
| Net Acquisitions | -$80 | -$12 | -$42 | -$34 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $5 | -$3 | $1 | $1 |
| Investing Cash Flow | -$114 | -$57 | -$66 | -$60 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $40 | -$15 | $36 | -$30 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$10 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$24 | -$26 | -$22 | -$21 |
| Financing Cash Flow | $15 | -$41 | $4 | -$51 |
| Forex Effect | -$4 | -$0 | -$7 | -$7 |
| Net Chg. in Cash | $14 | -$4 | -$9 | -$17 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $73 | $77 | $85 | $102 |
| End Cash | $86 | $73 | $77 | $85 |
| Free Cash Flow | $89 | $65 | $44 | $84 |